Aldeyra Therapeutics Inc(ALDX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALDX Aldeyra Therapeutics Inc

休市中 12-20 15:59:59 EST

4.88

+0.02

+0.41%

盘后4.98

+0.10+2.05%

19:06 EST

最高5.02	最低4.79	成交量43.04万
今开4.81	昨收4.86	日振幅4.73%
总市值2.91亿	流通市值2.11亿	总股本5,955万
成交额209.90万	换手率0.99%	流通股本4,326万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALDX","market":"US","secType":"STK","nameCN":"Aldeyra Therapeutics Inc","latestPrice":4.88,"timestamp":1734728399999,"preClose":4.86,"halted":0,"volume":430357,"hourTrading":{"tag":"盘后","latestPrice":4.98,"preClose":4.88,"latestTime":"19:06 EST","volume":28029,"amount":136791.44,"timestamp":1734739618503},"delay":0,"floatShares":43259662,"shares":59549598,"eps":-0.754272,"marketStatus":"休市中","marketStatusCode":7,"change":0.02,"latestTime":"12-20 15:59:59 EST","open":4.81,"high":5.02,"low":4.79,"amount":2098989.965204,"amplitude":0.047325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.754272,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1399003200000,"adjPreClose":4.86,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.92,"preClose":4.86,"latestTime":"09:28 EST","volume":10076,"amount":47305.899054,"timestamp":1734704901091},"postHourTrading":{"tag":"盘后","latestPrice":4.98,"preClose":4.88,"latestTime":"19:06 EST","volume":28029,"amount":136791.44,"timestamp":1734739618503},"volumeRatio":0.9973198264506492,"impliedVol":0.5875,"impliedVolPercentile":0.1746},"requestUrl":"/m/hq/s/ALDX","defaultTab":"news","newsList":[{"id":"2492160153","title":"Aldeyra Therapeutics, Inc.盘中异动 下午盘急速下跌5.07%报5.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492160153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492160153?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:16","pubTimestamp":1734549407,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时16分，Aldeyra Therapeutics, Inc.股票出现异动，股价急速下跌5.07%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.53%。其相关个股中，Polyrizon Ltd.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Cognition Therapeutics, Inc.涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3137.92%、645.43%、342.30%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、127.32%、105.17%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219031647ab827cef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219031647ab827cef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALDX","LENZ"],"gpt_icon":0},{"id":"2491339872","title":"Aldeyra Therapeutics, Inc.盘中异动 大幅下跌5.03%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491339872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491339872?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:38","pubTimestamp":1734021499,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时38分，Aldeyra Therapeutics, Inc.股票出现异动，股价急速下跌5.03%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.05%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213003819984b9ba7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213003819984b9ba7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2489234176","title":"Aldeyra Therapeutics, Inc.盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489234176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489234176?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:15","pubTimestamp":1733498109,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时15分，Aldeyra Therapeutics, Inc.股票出现异动，股价快速上涨5.05%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Adc Therapeutics Sa、Cardio Diagnostics Holdings Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为49.68%、36.98%、24.77%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cardio Diagnostics Holdings Inc.，振幅分别为27.68%、26.58%、24.33%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231509971c2704&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206231509971c2704&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALDX"],"gpt_icon":0},{"id":"2489427911","title":"Aldeyra Therapeutics, Inc.盘中异动 临近收盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489427911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489427911?lang=zh_cn&edition=full","pubTime":"2024-12-05 04:56","pubTimestamp":1733345811,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日04时56分，Aldeyra Therapeutics, Inc.股票出现波动，股价快速拉升5.06%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Cyclerion Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、蓝鸟生物涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为5166.30%、291.24%、150.49%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为584.69%、301.86%、138.61%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205045651ab5dd92c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205045651ab5dd92c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":0},{"id":"2485446162","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.15%报5.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485446162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485446162?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:31","pubTimestamp":1732213877,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时31分，Aldeyra Therapeutics, Inc.股票出现波动，股价大幅上涨5.15%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cidara Therapeutics, Inc.、Briacell Therapeutics Corp.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为956.11%、531.22%、394.59%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biodexa Pharmaceuticals Plc、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为162.20%、81.04%、76.33%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202311798e43fcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202311798e43fcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALDX"],"gpt_icon":0},{"id":"2484291089","title":"Aldeyra Therapeutics, Inc.盘中异动 大幅拉升5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484291089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484291089?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:25","pubTimestamp":1732029929,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时25分，Aldeyra Therapeutics, Inc.股票出现波动，股价急速拉升5.32%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.26%。其相关个股中，Exicure, Inc.、Dermata Therapeutics Inc C/Wts 、Fresh2 Group Limited涨幅较大，Tff Pharmaceuticals, Inc.、Exicure, Inc.、Hcw Biologics Inc.较为活跃，换手率分别为704.33%、101.87%、100.62%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为81.67%、62.18%、52.14%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119232529abcf824c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119232529abcf824c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":0},{"id":"2484694581","title":"FDA接受Aldeyra Therapeutics(ALDX.US)潜在“first-in-class”干眼症疗法上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2484694581","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484694581?lang=zh_cn&edition=full","pubTime":"2024-11-19 20:33","pubTimestamp":1732019631,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Aldeyra Therapeutics(ALDX.US)今日(11月19日)宣布，美国FDA已受理其所重新提交用于治疗干眼症的创新眼用药物reproxalap的新药申请(NDA)，该申请的PDUFA日期为2025年4月2日。与此同时，Aldeyra还宣布扩大与艾伯维(AbbVie)之间的独家选择权协议范围。Reproxalap是一款潜在“first-in-class”的在研小分子活性醛化物质抑制剂。活性醛化物质含量会在眼部或系统性发炎时上升，造成眼睛发炎、泪水分泌降低、眼睛发红以及改变泪水内脂质组成，许多干眼症患者具有较高的活性醛化物质含量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1213097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","LENZ","ALDX"],"gpt_icon":0},{"id":"2484676342","title":"Aldeyra Therapeutics, Inc.股价拉升15.91% 市值涨4623.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676342?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:31","pubTimestamp":1731940288,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时31分，Aldeyra Therapeutics, Inc.股票出现波动，股价快速上涨15.91%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Hcw Biologics Inc.、冠科美博、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为514.42%、179.03%、175.14%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Innate Pharma、Regenxbio Inc.，振幅分别为11.85%、10.42%、7.48%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312895be4821&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822312895be4821&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2483388776","title":"Aldeyra Therapeutics, Inc.盘中异动 大幅下挫5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483388776?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:13","pubTimestamp":1731510796,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时13分，Aldeyra Therapeutics, Inc.股票出现异动，股价急速跳水5.15%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Lexeo Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为368.30%、224.21%、93.93%，振幅较大的相关个股有Lexeo Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kairos Pharma, Ltd.，振幅分别为44.21%、36.31%、28.72%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113231316971a650e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113231316971a650e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALDX","LENZ"],"gpt_icon":0},{"id":"2482089994","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大跌5.10%报5.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482089994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482089994?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:54","pubTimestamp":1731423284,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时54分，Aldeyra Therapeutics, Inc.股票出现波动，股价急速下跌5.10%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222544498e4218a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222544498e4218a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALDX","LENZ"],"gpt_icon":0},{"id":"2480584496","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大跌5.04%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584496?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:50","pubTimestamp":1730731829,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时50分，Aldeyra Therapeutics, Inc.股票出现异动，股价快速下挫5.04%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Neurogene Inc.、Disc Medicine, Inc.、Tenaya Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为254.06%、171.28%、54.60%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.，振幅分别为31.90%、29.83%、25.56%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225029a215524f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225029a215524f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALDX"],"gpt_icon":0},{"id":"2479743724","title":"Aldeyra Therapeutics Inc  预计每股亏损 25 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479743724","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479743724?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:30","pubTimestamp":1730345404,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics Inc  预计每股亏损 25 美分 - 财报前瞻Aldeyra Therapeutics Inc ALDX.OQ ALDX.O预计在11月1日公布截至2024年9月30日的业绩时，季度收入将没有变化() LSEG分析师对Aldeyra Therapeutics Inc的平均预期是每股亏损25美分。华尔街对 Aldeyra Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 5.34 美元。10月31日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nL4T3M70LX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX"],"gpt_icon":0},{"id":"2477332279","title":"Aldeyra Therapeutics, Inc.盘中异动 早盘急速上涨6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477332279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477332279?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:32","pubTimestamp":1729603965,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时32分，Aldeyra Therapeutics, Inc.股票出现异动，股价大幅拉升6.33%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Tc Biopharm  Plc涨幅较大，Genprex, Inc.、Tc Biopharm  Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为1961.89%、1146.12%、1124.57%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Ensysce Biosciences, Inc.、Genprex, Inc.，振幅分别为67.84%、48.54%、25.83%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221324598e3dc39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221324598e3dc39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2475105689","title":"Aldeyra Therapeutics, Inc.盘中异动 大幅拉升5.41%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475105689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475105689?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:33","pubTimestamp":1729092833,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时33分，Aldeyra Therapeutics, Inc.股票出现波动，股价急速上涨5.41%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，180 Life Sciences Corp.、Korro Bio, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6113.78%、1085.07%、593.83%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.，振幅分别为623.68%、279.52%、126.58%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016233353a1e12305&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016233353a1e12305&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALDX"],"gpt_icon":0},{"id":"2472650645","title":"BUZZ--美国股票走势-第一基金会、InvenTrust 地产公司、能源股","url":"https://stock-news.laohu8.com/highlight/detail?id=2472650645","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472650645?lang=zh_cn&edition=full","pubTime":"2024-10-04 00:27","pubTimestamp":1727972847,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月3日 - 华尔街主要股指周四涨跌不一，此前数据显示世界最大经济体的服务业活动强劲，谨慎的投资者则在关注中东冲突是否会升级。美东时间11:40，道琼斯工业平均指数  下跌0.4%，报42031.97点。标普500指数  下跌0.15%，报5700.96点；纳斯达克综合指数  下跌0.06%，报17913.683点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BILI","PDD","NIO","EVGO","LEVI","BK4220","EPRT","LU1992135472.HKD","LU1992135399.USD","SM",".SPX","LU0055631609.USD","NEM","DDM","CHPT","LU0345780950.USD","HAL","LU0098860793.USD",".DJI","UDOW","DJX","VLO","PNTG","LU0056508442.USD","LU0072462343.USD",".IXIC","LU0368265764.SGD","LI","DOG","FFWM","IE00BLSP4452.SGD","RNA","BK4096","XPEV","GEV","IVT","L","CAG","BABA","STZ","SDOW","FCX","HIMS","WOLF","LU0052750758.USD","LUV","JD","BK4531","BAC","LU0122376428.USD","ULTA","EQT","BLBD","SCCO","DXD"],"gpt_icon":1},{"id":"2472615945","title":"BUZZ--美国股票走势-西南航空公司、EQT 公司、Avidity 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2472615945","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472615945?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:24","pubTimestamp":1727961866,"startTime":"0","endTime":"0","summary":".N 美东时间9:06，道指电子盘<1YMc1>下跌0.33%，报42,371点。标普500指数下跌0.27%，报5744.75点；纳斯达克100指数下跌0.45%，报19920点。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241003:nL4S3LF0UM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","ADV","CETX","CHPT","EQT","BK4574","LU0456846285.SGD","ADN","LUV","L","BYD","BK4579","BTBD","LU0456842615.SGD","ULTA","LEVI","BAC","LU1861215975.USD","EVS.SI","IE00BBT3K403.USD","PNTG","LU0880133367.SGD","EVGO","BKSY","PEGY","HIMS","WOLF","89618","CNF","ELAB","RNA","LU0256863902.USD","DAO","NEM"],"gpt_icon":1},{"id":"2472690619","title":"BUZZ-重新提交眼疾药物申请后，Aldeyra 公司业绩上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2472690619","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472690619?lang=zh_cn&edition=full","pubTime":"2024-10-03 20:42","pubTimestamp":1727959340,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月3日 - ** Aldeyra Therapeutics    股价盘前上涨 1.9% 至 5.40 美元** 该公司称已向美国食品及药物管理局重新提交了干眼症药物的审批申请** 去年，美国食品和药物管理局拒绝批准 (link) 药物 reproxalap ** 截至上次收盘，股价累计上涨 51","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"2470080091","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470080091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470080091?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:06","pubTimestamp":1727449579,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时06分，Aldeyra Therapeutics, Inc.股票出现异动，股价大幅上涨5.40%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092723061998e396f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092723061998e396f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALDX"],"gpt_icon":0},{"id":"2469671525","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469671525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469671525?lang=zh_cn&edition=full","pubTime":"2024-09-21 00:59","pubTimestamp":1726851548,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日00时59分，Aldeyra Therapeutics, Inc.股票出现波动，股价急速下跌5.13%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.13%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921005908a1db7b04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921005908a1db7b04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALDX"],"gpt_icon":0},{"id":"2460342590","title":"Aldeyra Therapeutics, Inc.盘中异动 急速上涨5.13%报5.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460342590","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460342590?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:36","pubTimestamp":1724074600,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时36分，Aldeyra Therapeutics, Inc.股票出现波动，股价大幅拉升5.13%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Cingulate Inc.较为活跃，换手率分别为2525.35%、1448.33%、350.40%，振幅较大的相关个股有Alzamend Neuro, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Virax Biolabs Group Limited，振幅分别为82.83%、70.11%、41.78%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921364097199210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921364097199210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALDX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aldeyra.com","stockEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0252},{"period":"3month","weight":-0.1715},{"period":"6month","weight":0.4023},{"period":"1year","weight":0.4567},{"period":"ytd","weight":0.3903}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aldeyra Therapeutics, Inc.于2004年8月13日在特拉华州注册成立，名称为Neuron Systems，Inc.。该公司是一家生物技术公司，主要专注于开发产品，以治疗免疫介导的、炎症的、孤儿的以及被认为与一种称为游离醛的天然有毒化学物种有关的疾病。Aldeyra Therapeutics正在开发下一代药物，以改善免疫介导疾病患者的生活。Aldeyra的主要候选产品reproxalap是一种用于干眼症和眼部炎症形式的晚期开发的first-in-class治疗。Aldeyra还在为自身免疫性疾病、移植后淋巴组织增生性疾病、视网膜炎症、代谢性疾病和癌症开发候选产品。Aldeyra的候选产品均未获准在美国。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.077344},{"month":2,"riseRate":0.6,"avgChangeRate":0.000014},{"month":3,"riseRate":0.4,"avgChangeRate":-0.001859},{"month":4,"riseRate":0.5,"avgChangeRate":0.045254},{"month":5,"riseRate":0.4,"avgChangeRate":0.032473},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.035553},{"month":7,"riseRate":0.545455,"avgChangeRate":0.029811},{"month":8,"riseRate":0.454545,"avgChangeRate":0.039547},{"month":9,"riseRate":0.545455,"avgChangeRate":0.194872},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.097688},{"month":11,"riseRate":0.636364,"avgChangeRate":0.079434},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.031878}],"exchange":"NASDAQ","name":"Aldeyra Therapeutics Inc","nameEN":"Aldeyra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aldeyra Therapeutics Inc(ALDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aldeyra Therapeutics Inc(ALDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aldeyra Therapeutics Inc,ALDX,Aldeyra Therapeutics Inc股票,Aldeyra Therapeutics Inc股票老虎,Aldeyra Therapeutics Inc股票老虎国际,Aldeyra Therapeutics Inc行情,Aldeyra Therapeutics Inc股票行情,Aldeyra Therapeutics Inc股价,Aldeyra Therapeutics Inc股市,Aldeyra Therapeutics Inc股票价格,Aldeyra Therapeutics Inc股票交易,Aldeyra Therapeutics Inc股票购买,Aldeyra Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aldeyra Therapeutics Inc(ALDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aldeyra Therapeutics Inc(ALDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}